Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PAMVAC-VLP by AdaptVac for Malaria: Likelihood of Approval
PAMVAC-VLP is under clinical development by AdaptVac and currently in Phase I for Malaria. According to GlobalData, Phase I drugs...